Protocol No.: A221805
- Title
- Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-induced Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase II to Phase II Study
- Principal Investigator
- Daboul, Nour
- Phase
- II/III
- Age Group
- Adult
- Applicable Disease Site
- Gastrointestinal Cancers
- Participating Institution
- Mary Babb Randolph Cancer Center
- Contacts
- Sabrina Rexroad, RN
- Research Nurse
- Phone: +1 304-293-6066
- Email: sabrina.martinvernon@hsc.wvu.edu
- Valli White, RN
- Research Nurse
- Phone: +1 304-264-1220
- Email: valli.white@wvumedicine.org
- Maher Kali, MD
- Clinical Research Specialist
- Phone: +1 304-243-7045
- Email: maher.kali@wvumedicine.org
- Layla Tannoury
- Clinical Research Specialist
- Phone: +1 304-424-2585
- Email: layla.tannoury@wvumedicine.org